VOX vs XBI
Vanguard Communication Services ETF vs SPDR S&P Biotech ETF
- • VOX has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VOX pays a higher dividend yield (0.96%).
Side-by-side metrics
| Metric | VOX | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.96% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $6.32B | $8.30B |
YTD return | 2.67% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 1.09 |
P/E ratio | 21.09 | — |
Last price | $198.12 | $133.66 |
Inception | — | — |
Issuer | Vanguard | State Street |
VOX top holdings
| META | Meta Platforms Inc Class A | 20.58% |
| GOOGL | Alphabet Inc Class A | 13.14% |
| GOOG | Alphabet Inc Class C | 8.71% |
| NFLX | Netflix Inc | 5.74% |
| VZ | Verizon Communications Inc | 4.72% |
| T | AT&T Inc | 4.65% |
| DIS | The Walt Disney Co | 4.04% |
| TMUS | T-Mobile US Inc | 3.02% |
| WBD | Warner Bros. Discovery Inc Ordinary Shares - Class A | 3.00% |
| CMCSA | Comcast Corp Class A | 2.93% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About VOX
VOX (Vanguard Communication Services ETF) is US communication services sector stocks. Managed by Vanguard, the fund carries $6.3B in assets under management, an expense ratio of 0.09%, a dividend yield of 0.96%. Its largest holding is Meta Platforms Inc Class A (META), which represents 20.6% of the portfolio. Real Estate is the fund's largest sector exposure at 0.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.